Purchases and Sales Made in Q2 2023 in Anebulo Pharmaceuticals, Inc. (ANEB)
This table provides information about the institutional ownership of Anebulo Pharmaceuticals, Inc. (ANEB) during Q2 2023. The information is specifically focused on institutions that hold shares of Anebulo Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2023
Q2 2023
|
Praetorian Pr LLC
Rincon, PR |
BUY
|
- |
180KNew |
$371K - $536K
|
180K
$292K
|
|
Aug 14, 2023
Q2 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
16KNew |
$33K - $47.8K
|
16K
$26K
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
994+ 19.46% |
$2.05K - $2.96K
|
6.1K
$9.88K
|
|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
48New |
$98.9 - $143
|
48
$77.8
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
2+ 3.64% |
$4.12 - $5.96
|
57
$92.3
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 11, 2023
Q2 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-280- 3.72% |
$577 - $834
|
7.25K
$11.7K
|
|
Jul 14, 2023
Q2 2023
|
Lvw Advisors, LLC
|
SELL
|
- |
-1K- 0.15% |
$2.06K - $2.98K
|
672K
$1.09M
|